Document Type
Article
Publication Date
4-1-2019
Abstract
AIM: To evaluate Medicaid spending and healthcare resource utilization (HRU) in treatment-resistant depression (TRD).
MATERIALS & METHODS: TRD beneficiaries were identified from Medicaid claims databases (January 2010-March 2017) and matched 1:1 with major depressive disorder (MDD) beneficiaries without TRD (non-TRD-MDD) and randomly selected patients without MDD (non-MDD). Differences in HRU and per-patient-per-year costs were reported in incidence rate ratios (IRRs) and cost differences (CDs), respectively.
RESULTS: TRD beneficiaries had higher HRU than 1:1 matched non-TRD-MDD (e.g., inpatient visits: IRR = 1.41) and non-MDD beneficiaries (N = 14,710 per cohort; e.g., inpatient visits: IRR = 3.42, p < 0.01). TRD beneficiaries incurred greater costs versus non-TRD-MDD (CD = US$4382) and non-MDD beneficiaries (CD = US$8294; p < 0.05).
CONCLUSION: TRD is associated with higher HRU and costs versus non-TRD-MDD and non-MDD. TRD poses a significant burden to Medicaid.
Recommended Citation
Pilon, Dominic; Sheehan, John J.; Szukis, Holly; Singer, David; Jacques, Philippe; Lejeune, Dominique; Lefebvre, Patrick; and Greenberg, Paul E., "Medicaid spending burden among beneficiaries with treatment-resistant depression." (2019). College of Population Health Faculty Papers. Paper 87.
https://jdc.jefferson.edu/healthpolicyfaculty/87
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Language
English
Comments
This article has been peer reviewed. It is the author’s final published version in Journal of Comparative Effectiveness Research, Volume 8, Issue 6, April 2019, Pages 381-391.
The published version is available at https://doi.org/10.2217/cer-2018-0140. Copyright © Pilon et al.